🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

PhD vacancy alert! 📣 Do you have experience with neuroimaging, programming skills, a fascination for the brain🧠, and would like to work in a highly international group? This position is for you! Check out the website👇 werkenbij.amsterdamumc.org/en/vacatures/r… Frederik Barkhof Henk(—Jan) Mutsaerts (he/him)

If you're joining 🇵🇹#ADPD2024🧠 this week, don't miss the BioFINDER posters and presentations! #Plasma #asynuclein #ALS #MachineLearning #TauPET #PrimaryCare #SVD #proteomics #sexDifferences #ptau #CSF #biomarkers #Alzheimer and many other topics! 🩸🧬♀️♂️🩺💉

Great first time presentation by Leonard Pieperhoff at #ADPD2024 about the AMYPAD longitudinal imaging data! 😎 Note, the data is openly available, check out our website to gain access! 👇 AMYPAD.eu

Last but not least... For those still in Lisbon for #ADPD2024, our group still has some interesting projects to present

New preprint from AMYPAD out📢 Using a prospective study design, we showed that quantification🔢 of amyloid-PET scans🧠improves the visual assessment agreement🧐and confidence 💪between 5 readers. The study was enriched for challenging cases🤔. medrxiv.org/cgi/content/sh…

#AAIC24 started this morning with an interactive educational session on Amyloid PET Quantification. Thanks to all speakers & delegates🤗 👉Today stop by Poster 88788 from Dr Emma Luckett "Associations between AD polygenic risk scores & global amyloid deposition in AMYPAD"

For all the Europeans that don't understand ounces at the #AAIC2024 😂👌

The AMYPAD study is advancing research, aiming to improve #Alzheimer’s modelling efforts. This dataset includes cognition data, disease biomarkers, genetic and environmental risk factors, and other relevant variables. bit.ly/ADWorkbench

🚨New publication led by Lyduine Collij ‼️ Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease” shows the exacerbating effects of a-synuclein co-pathology in Alzheimer's disease. Now published in Nature Communications ! nature.com/articles/s4146…

We had a fantastic day yesterday at the EU-MIND Congress! If you're attending #EUMind2024, don’t miss Lyduine Collij's presentation today on 'From AMYPAD to #EuroPAD – creating a multi-cohort preclinical database to model AD disease trajectories.' #EUMIND

🙌Pleased to be part of the first EU-MIND Congress this week 🇫🇷 Special shout-out to Leo Pieperhoff & Lyduine Collij for showcasing the AMYPAD project and its Prognostic and Natural History Study dataset available through the Alzheimer's Disease Data Initiative #ADWorkbench⤵️ amypad.eu/news/recent-ne…

Today I will be presenting "Use of plasma p-tau217 to identify Aβ-positive cognitively unimpaired participants for clinical trials: A multicohort stud" at CTAD (OC-29, 4:40pm CEST).

Honored to have been awarded the Alzheimer Nederland Research Talent Award! 🤓 Extremely proud for my work to be recognized to have scientific and societal impact 🏥 Thanks to everyone who made this work possible 🙏 Frederik Barkhof AMYPAD Alzheimercentrum Amsterdam (inactief) RikOssenkoppele Oskar Hansson

Does amyloid-PET quantification really support visual assessment❓ Yes❗ In this latest AMYPAD paper, we show how the value of quant in challenging clinical cases 🧐 Check out the paper below 👇 Valentina Garibotto Silvia Morbelli Frederik Barkhof

📢New paper out❗️We present the context-of-use of the robust and generalizable Centiloid scale in the clinical routine 🏥 and in the context of DMTs💊. What a timing after the amazing news from last Thursday on Lecanemab!🤓 Academia-EFPIA collaborations were key! AMYPAD

The AMYPAD Prognostic and Natural History Study has had a successful year💥 Visit our website to get an overview of the data accessibility, a snapshot of 2024, and a glimpse into the future with the #EuroPAD community ⤵️ amypad.eu/news/recent-ne…